Sun exposure may protect against non-Hodgkin lymphoma: A case-control study

International Journal of Cancer

Volumn 112, Issue 5, 2004, Pages 865-871

  Hughes, Ann Maree ^a   Armstrong, Bruce K ^a   Vajdic, Claire M ^b   Turner, Jennifer ^c   Grulich, Andrew E ^b   Fritschi, Lin ^d   Milliken, Sam ^c   Kaldor, John ^b   Benke, Geza ^e   Kricker, Anne ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Aetiology; Case control study; Non Hodgkin lymphoma; Sun exposure; UV radiation

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; ETHNOLOGY; FEMALE; FREQUENCY ANALYSIS; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTECTION; RANDOMIZATION; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SUN EXPOSURE; TELEPHONE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SUNLIGHT; ULTRAVIOLET RAYS; VITAMIN D;

EID: 7244224775     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20470     Document Type: Article

References (63)

1. Cartwright RA, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leukaemia Lymphoma 1994;14:387-94.
2. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996;73:945-50.
3. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. Br Med J 1996;312:1128-31.
4. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF, Jr. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer I 1996;88:298-300.
5. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. Br Med J 1997;314:1451-5.
6. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75.
7. Hu S, Ma F, Collado-Mesa F, Kirsner RS. Ultraviolet radiation and incidence of non-Hodgkin's Lymphoma among Hispanics in the United States. Cancer Epidem Biomar 2004;13:59-64.
8. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995;310:1491-5.
9. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847-50.
10. Hughes AM, Armstrong BK, Vajdic C, Turner J, Grulich A, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A. Pigmentary characteristics, sun-sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004;110:429-34.
11. Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, Anderson T, Koren H. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose. CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A 1992;89:8497-501.
12. Kinlen LJ. Immunosuppressive therapy and acquired immunological disorders. Cancer Res 1992;52:5474s-6s.
13. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-6.
14. Hardell L, Eriksson M, Degerman A. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma. Cancer Res 1994;54:2386-9.
15. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, Ekbom A, Zahm SH. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641-5.
16. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12:552-7.
17. van Wijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 2001;43:548-53.
18. Tracey E, Supramaniam R. Cancer in New South Wales Incidence and mortality 2000 featuring projections to 2010 for selected sites. Sydney: The Cancer Council NSW, 2002.
19. Tracey EA, Supramaniam R, Chen W. Cancer in New South Wales: incidence and mortality 2001. Sydney: The Cancer Council NSW, 2003.
20. Turner JJ, Hughes AM, Kricker A, Milliken S, Grulich A, Kaldor J, Armstrong B. Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol 2004;15:631-7.
21. UNAIDS. Report on the global HIV/AIDS epidemic 2002. Geneva: UNAIDS, 2002.
22. Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482-8.
23. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles G, Armstrong BK. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002;101:175-82.
24. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 1995;60:489-94.
25. English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidem Biomar 1998;7:857-63.
26. Vajdic, C. M. Sun exposure and ocular melanoma in Australia. PhD thesis, School of Public Health, University of Sydney, 2001.
27. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18.
28. Bureau of Meteorology. Laboratory and radiation sub-section solar exposure data 1947-1998. (Version NCCSOL 2.204, 8 February 1999). Melbourne: Bureau of Meteorology, 1999.
29. International Research Institute for Climate Prediction, Columbia University. International Satellite Cloud Climatology Project: solar radiation and cloudiness. Available from: http://ingrid.ldgo.columbia.edu/SOURCES/.ISCCP/. MONTHLY/.solr, 1999.
30. National Centre for Atmospheric Research, Atmospheric Chemistry Division. Tropospheric Ultraviolet and Visible Radiation Model, version 4.1. Internet, 2002.
31. Elwood JM, Diffey BL. A consideration of ambient solar ultraviolet radiation in the interpretation of studies of the aetiology of melanoma. Melanoma Res 1993;3:113-22.
32. Australian Bureau of Statistics. Socio-Economic Indexes for Areas, Australia. ABS Catalog No. 2039.0. ABS Catalog No. 2039.0. 2-10-1998. Commonwealth of Australia, Canberra.
33. Australian Bureau of Statistics. How Australians use their time. ABS Catalog No. 4153.0. ABS Catalog No. 4153.0. 1998. Commonwealth of Australia, Canberra.
34. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998;9:717-20.
35. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol 1999;128:280-7.
36. Brownson RC, Reif JS. A cancer registry-based study of occupational risk for lymphoma, multiple myeloma and leukaemia. Int J Epidemiol 1988;17:27-32.
37. Cantor KP. Farming and mortality from non-Hodgkin's lymphoma: a case-control study. Int J Cancer 1982;29:239-47.
38. Ronco G, Costa G, Lynge E. Cancer risk among Danish and Italian farmers. Br J Ind Med 1992;49:220-5.
39. Kelleher C, Newell J, MacDonagh-White C, MacHale E, Egan E, Connolly E, Gough H, Delaney B, Shryane E. Incidence and occupational pattern of leukaemias, lymphomas, and testicular tumours in western Ireland over an 11 year period. J Epidemiol Commun H 1998;52:651-6.
40. Morison WL. Phototherapy and photochemotherapy of skin disease. New York: Raven Press, 1991.
41. Woods JS, Polissar L, Severson RK, Heuser LS, Kulander BG. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington. J Natl Cancer I 1987;78:899-910.
42. Ullrich SE. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol 1996;64:254-8.
43. Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000;14:133-40.
44. Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 1999;8:979-84.
45. Vineis P, Miligi L, Crosignani P, Fontana A, Masala G, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, Vindigni C, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000;54:907-11.
46. Doody MM, Linet MS, Glass AG, Friedman GD, Pottern LM, Boice JD Jr, Fraumeni JF Jr. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 1992;3:449-56.
47. Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev. 2000;9:59-64.
48. Holly EA, Bracci PM. Population-based study of non-hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003;158:316-27.
49. Studzinski GP, Moore DC. Sunlight - can it prevent as well as cause cancer? Cancer Res 1995;55:4014-22.
50. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181-3.
51. Hickish T, Cunningham D, Colston K, Millar BC, Sandle J, Mackay AG, Soukop M, Sloane J. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993;68:668-72.
52. Majewski S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Investig Dermatol Symp Proc 1996;1:97-101.
53. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176-8.
54. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Cause Control 2000;11:847-52.
55. Levine AJ, Harper JM, Ervin CM, Chen YN, Harmon E, Xue S, Lee ER, Frankel HD, Haile RW. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001;39:35-41.
56. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108:104-8.
57. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002;59:257-62.
58. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Ramachandran S, Fryer AA, Strange RC. Susceptibility to prostate cancer, studies on interactions between UVR exposure and skin type. Carcinogenesis 2003;24:711-7.
59. Webb AR, Holick MF. The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr 1988;8:375-99.
60. Holick MF. McCollum Award Lecture. 1994: vitamin D: new horizons for the 21st century. Am J Clin Nutr 1994;60:619-30.
61. DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56:S4-10.
62. Boonstra A, Barrat FJ, Grain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha.25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974-80.
63. Reichrath J, Rappl G. Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link? J Cell Biochem 2003;89:6-8.